Bristol Myers Squibb Launches Could It Be HCM? Campaign to Increase Awareness of Hypertrophic Cardiomyopathy , the Most Common Inherited Heart Disease Pharmaceutical Investing
BMY, EAR, HMLP SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set Pharmaceutical Investing
BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences Life Science Investing
LUMYKRAS® Receives Positive Opinion From EMA CHMP For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer Market News
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, EAR, HYZN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint Pharmaceutical Investing
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights Pharmaceutical Investing
Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Pharmaceutical Investing
